Corning and ATCC Extend Collaboration to Advance Cell Culture Research

Image Alt Text

Corning and ATCC Extend Collaboration to Advance Cell Culture Research

Corning and ATCC Extend Collaboration to Advance C

News Releases
Life Sciences
Corning and ATCC Extend Collaboration to Advance Cell Culture Research
Corning and ATCC Extend Collaboration to Advance Cell Culture Research
CORNING, N.Y. and MANASSAS, V.A. | Corning Incorporated | 2014年3月27日
Industry leaders to co-develop and co-market new applications for existing ATCC cell types and Corning products 

Corning Incorporated (NYSE: GLW) and ATCC today extended an existing collaboration that will benefit cell culture researchers worldwide. Under terms of the agreement, Corning Life Sciences and ATCC will co-develop new applications for existing ATCC and Corning cell biology products; provide researchers with increased access to knowledgeable field scientists and information; and participate in joint marketing initiatives.

“We are excited to expand our relationship with ATCC,” said Brian Douglass, business director, Cell Culture, Corning Life Sciences. “Through our continued work, customers will have quicker access to more resources, information, and technical approaches to accelerate their research.”

Together, ATCC and Corning both offer a wealth of cell culture knowledge and information that researchers can access to improve productivity. Additionally,  new application development for existing ATCC cells — primary, iPSCs, and hTERT immortalized cell lines—will provide improved workflow and new insights into ways Corning’s differentiated products, such as  Corning® BioCoat™, can improve performance.
“We continually strive to acquire, authenticate, preserve, develop, standardize, and distribute biological materials and information for the advancement of scientific research,” said Matthew Klusas, senior director, Corporate Development, ATCC. “This collaboration with Corning Life Sciences helps us further accomplish that mission by providing our customers with value-added cell culture solutions.”
Through acquisition and ongoing R&D investment, Corning offers a leading portfolio of premium, innovative laboratory products and solutions for a wide spectrum of life science applications. Corning’s trusted quality brands, backed by technical expertise, provide researchers with better ways to advance their research from the beginning of their process to the end. The family of brands includes Corning®, PYREX®, Falcon®, Axygen®, and Gosselin™.

To learn more about Corning Life Sciences products, please contact a customer service representative at 1-800-492-1110, toll free in the United States; (+1) 1-978-442-2200 internationally; or visit

For more information about ATCC products, contact ATCC technical service representatives toll free in the U.S. at 1-800-638-6597; for international inquiries, please call (703) 365-2700 or visit

Forward-Looking and Cautionary Statements
This press release contains “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995), which are based on current expectations and assumptions about Corning’s financial results and business operations, that involve substantial risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include: the effect of global political, economic and business conditions; conditions in the financial and credit markets; currency fluctuations; tax rates; product demand and industry capacity; competition; reliance on a concentrated customer base; manufacturing efficiencies; cost reductions; availability of critical components and materials; new product commercialization; pricing fluctuations and changes in the mix of sales between premium and non-premium products; new plant start-up or restructuring costs; possible disruption in commercial activities due to terrorist activity, armed conflict, political or financial instability, natural disasters, adverse weather conditions, or major health concerns; adequacy of insurance; equity company activities; acquisition and divestiture activities; the level of excess or obsolete inventory; the rate of technology change; the ability to enforce patents; product and components performance issues; retention of key personnel; stock price fluctuations; and adverse litigation or regulatory developments. These and other risk factors are detailed in Corning’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the day that they are made, and Corning undertakes no obligation to update them in light of new information or future events.

About ATCC
ATCC, the premier global biological materials resource and standards organization, serves and supports the scientific community with industry-standard products and innovative solutions. With the world’s largest and most diverse collection of human, animal, and plant cell lines, as well as molecular genomic tools, microorganisms, and biological products, ATCC is a trusted biological resource for the worldwide research community.  ATCC is a non-profit organization with headquarters in Manassas, Va.

About Corning Incorporated
Corning Incorporated ( is the world leader in specialty glass and ceramics. Drawing on more than 160 years of materials science and process engineering knowledge, Corning creates and makes keystone components that enable high-technology systems for consumer electronics, mobile emissions control, telecommunications and life sciences. Our products include glass substrates for LCD televisions, computer monitors and laptops; ceramic substrates and filters for mobile emission control systems; optical fiber, cable, hardware & equipment for telecommunications networks; optical biosensors for drug discovery; and other advanced optics and specialty glass solutions for a number of industries including semiconductor, aerospace, defense, astronomy, and metrology.